REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/02/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of a stylized letter "G" partially encircled by three crescent-shaped bands above the wording "GERMAN INTERNATIONAL CLINICS".
Titulares
Representantes
Margaret C. McHugh KILPATRICK TOWNSEND & STOCKTON LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Medical and veterinary apparatus and instruments, namely, blood filters, blood purification filters, filters for removing toxins, pesticides, parasites, drugs, poisons, heavy metals, bacteria, viruses, immunopathogenic agents, bilirubin, and beta 2 microglobulin, drug delivery filters sold empty, fluid filters, peristaltic filters, artificial membrane filters, centrifugal pumps for blood preparation, blood transport, oxygen transport, adsorbers for blood purification, toxin, pesticide, parasite, drug, poison, heavy metal, bacteria, virus, immunopathogenic agent, bilirubin, and beta 2 microglobulin, heat exchangers, oxygenators, devices for ozone production in the nature of ozone generators, ozone devices for the treatment of blood, ozone devices for the killing and removal of bacteria, viruses, and parasites, tube systems comprised of tubes for passing blood and fluids, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, blood perfusion devices, perfusion devices for the treatment of blood, perfusion cutlery for surgery; medical and veterinary apparatus and instruments, namely, diagnostic and therapeutic equipment for use in the pharmaceutical, medical and veterinary fields, namely, equipment for blood gas analysis, devices for measuring blood coagulation, devices for measuring oxygen saturation, devices for measuring body temperature, hemoperfusion devices for the treatment of blood, clinical laboratory analyzers for blood and blood component analysis, chemistry analyzers for blood and blood component analysis, automated sample handling equipment for testing purposes, immunohematology analyzer for blood and blood component analysis, apparatus for blood screening, blood typing, and detection of assays associated with blood screening and blood typing used in the transfusion medicine market; Medical equipment for use in treating hyperthermia, and for thermotherapy, chemotherapy, electrochemical therapy, or radiotherapy, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy, infusion equipment sold empty for drug delivery, pain therapy, blood purification, and blood perfusion, radiotherapy equipment, and medical apparatus for treating diseases in the nature of cancer, borreliose, chronical diseases, and regenerative diseases, namely, filters, pumps, adsorbers, heat exchangers, oxygenators, ozone devices, tube systems, hemoperfusion devices, blood purification devices, devices for inducing hyperthermia, devices for thermotherapy, perfusion devices, and perfusion cutlery; medical apparatus for treating hyperthermia or carrying out apheresis, namely, heat exchangers, devices for inducing hyperthermia, devices for thermotherapy, and apheresis devices or units for filtering, purification, detoxification and separation of blood
Classe 44
Hygienic care for human beings or animals
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/02/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
30/05/2021
FINAL DISPOSITION NOTICE SENT TO IB
11/05/2021
FINAL DISPOSITION PROCESSED
11/05/2021
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/05/2021
REGISTERED-PRINCIPAL REGISTER
09/02/2021
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
23/01/2021
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/01/2021
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/01/2021
NOTIFICATION PROCESSED BY IB
19/12/2020
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/11/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/11/2020
PUBLISHED FOR OPPOSITION
24/11/2020
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/11/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/11/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
20/10/2020
EXAMINER'S AMENDMENT ENTERED
20/10/2020
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/10/2020
EXAMINERS AMENDMENT E-MAILED
20/10/2020
EXAMINERS AMENDMENT -WRITTEN
20/10/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2020
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2020
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/10/2020
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
04/08/2020
CONTINUATION OF FINAL REFUSAL E-MAILED
04/08/2020
ACTION CONTINUING A FINAL - COMPLETED
04/08/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2020
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2020
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/07/2020
NOTIFICATION OF FINAL REFUSAL EMAILED
13/04/2020
FINAL REFUSAL E-MAILED
13/04/2020
FINAL REFUSAL WRITTEN
13/04/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
20/03/2020
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/03/2020
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/03/2020
REFUSAL PROCESSED BY IB
26/10/2019
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/10/2019
REFUSAL PROCESSED BY MPU
05/10/2019
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/09/2019
NON-FINAL ACTION WRITTEN
19/09/2019
ASSIGNED TO EXAMINER
04/09/2019
APPLICATION FILING RECEIPT MAILED
13/08/2019
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2019
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/08/2019
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.